For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>

Contract Manufacturing

Cadila Pharmaceuticals undertakes contract manufacturing in the following categories and offers a mutually beneficial working relationship and a strong strategic alliance.

Generic Formulations

  • State-of-the art facilities, which adhere to stringent specifications of cGMP, TGA-Australia, and MCC-South Africa.
  • Production capacity of Tablets 3,900 million / year, Capsules 150 million / year, Liquids 6,000 kilo liters / year, Vials + Ampoules 168 million / year.
  • Capabilities to produce dosage forms in sterile and general, covering all therapeutic segments along with lyophilization facility.
  • Isolated and dedicated production facilities for Beta-Lactam, Cephalosporin, Rifampicin dosage forms and Insulin.
  • Qualified and experienced technical team in the areas of manufacturing, quality control, quality assurance, research and development for all range of products.
  • Experienced professionals and highly qualified management and staff, with SAP ERP and Supply Chain Management in place.

Active Pharmaceutical Ingredients (APIs)

  • Inspected & approved by USFDA for Fluoxetine and Ethambutol.
  • US DMF / EDMF / COS filed / under process for about 20 products.
  • ISO 9002 / ISO 14000 certified Bulk Actives manufacturing facility, offering facilities for “Contract Manufacturing”.
  • Product range: Active Pharmaceutical Ingredients
  • Anti-allergic, Cardiovascular, Anti-diabetic, Disinfectants,
  • CNS, NSAIDs, Anti-TB, Gastrointestinal, Anti-histamines

Economic Value of Strategic Alliance

  • Reliable supply of quality products – Validated and approved processes and in compliance with the registration file.
  • Minimize investments in capital-intensive facilities.
  • Improve net earning and cash flow.
  • Divert resources to focus on their core competencies – R&D and marketing.
  • All products are analyzed and released by our quality control staff before shipment.
  • Monitor and optimize the timeliness of our delivery and keep it up to our customer’s full satisfaction

Business Opportunities And Strategic Alliance With Cadila Pharmaceuticals

  • We offer contract manufacturing of all dosage forms.
  • Depending on your needs, our services include purchasing of raw materials, production, packaging and quality control.
  • Through this flexible approach, we are able to integrate perfectly into your supply chain for solid dosage forms.
Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals